KemPharm Inc (KMPH)

NASDAQ
6.21
+0.31(+5.25%)
  • Volume:
    62,293
  • Day's Range:
    6.02 - 6.28
  • 52 wk Range:
    4.00 - 10.80
Earnings results expected tomorrow

KMPH Overview

Prev. Close
5.9
Day's Range
6.02-6.28
Revenue
20.5M
Open
6.03
52 wk Range
4-10.8
EPS
-0.55
Volume
62,293
Market Cap
214.11M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
377,776
P/E Ratio
-
Beta
2.81
1-Year Change
-42.33%
Shares Outstanding
34,423,497
Next Earnings Date
Aug 11, 2022
What is your sentiment on KemPharm Inc?
or
Vote to see community's results!

KemPharm Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

KemPharm Inc Analysis

KemPharm Inc Company Profile

KemPharm Inc Company Profile

Employees
24

KemPharm, Inc. (KemPharm) is a specialty pharmaceutical company focused on the discovery and development of treatments for central nervous system (CNS), and rare disease indications, including attention deficit hyperactivity disorder (ADHD), stimulant use disorder (SUD) and idiopathic hypersomnia (IH). It is focused on the discovery and development of prodrugs to treat serious medical conditions through its Ligand Activated Therapy (LAT) technology. KemPharm utilizes its LAT technology to generate prodrug versions of Food and Drug Administration (FDA) approved drugs. KemPharm's lead clinical development product candidate for the treatment of IH and narcolepsy, KP1077, is based on serdexmethylphenidate (SDX), its prodrug of d-methlyphenidate (d-MPH). Its prodrug product candidate for the treatment of SUD is KP879. In addition, KemPharm has received FDA approval for AZSTARYS, a once-daily treatment for ADHD in patents age six years and older.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyStrong BuyStrong BuyStrong BuySell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
  • Late 4th quarter this trades the $20.00 handle. ✌😊🎯👨‍🎓
    1
    • why to go up to $20 bec you need money to make vacations give me a real reason please ?
      0
  • Y'all paying attention to the sales team Corium is putting together here? Basically the who's, who from Shire. This will trade the $20.00 handle + by December. 👨‍🎓🎯😊✌
    0
    • Volume is better now. Maybe we will be millionares.😁
      0
      • Sold at a loss. Starting a small position in EDR. UFC is great and it can only go up at this point
        2
        • 590mill pipeline....even better.Mcap is now 280mill. Wake up people.
          0
          • Now even a better deal is made. Kmph is about to recive cash and a 520 mill future plan payment is at hand.
            0
            • Ok, guys for those who held trough that dump. I belive the star will shine upon u.
              0
              • KMPH taking some here for a swing incase they come for it for the short interest of 71%, They have 2 approved drugs and 8 seems to be a good support, not bad R/R from this level! Is what he said. The short interest must be at float. I can,t see 70% og all 32mill stock.
                0
                • Is this 70% of float shorted? Acording to finviz it is
                  0
                  • Will Meade twitted about it.
                    0
                  • Eric Gagnon thanks he has so high autority to rise the stock on 4.3$ wow
                    0
                  • If it was elon i would belive it. PM him an tell him to hype the stonk. He is an adhd guy.
                    0
                • 20 today? it's possible I think
                  0